Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00766558 · ClinicalTrials.gov registry record
The Effects of Written Emotional Disclosure on Eating Disorder Pathology in a Clinical Eating Disordered Population
A clinical trial, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- 29
- Enrollment target
NCT00766558: Completed study, sponsored by Milton S. Hershey Medical Center.
NCT00766558 is a clinical trial that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 29 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00766558 has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- 29 participants
- Enrollment target
Study Summary
A technique that has been found to be effective at relieving the physical and psychological symptoms associated with inhibiting emotions and emotional thoughts is written emotional disclosure. The goal of this study is to evaluate the effectiveness of written emotional disclosure on the remediation of eating disorder behaviour, cognitions, and management of emotions.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2009-06 |
| Est. Completion | 2013-07 |
What the finished NCT00766558 record still lists
NCT00766558 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 29 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00766558 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00766558 about?
NCT00766558 is a clinical study titled "The Effects of Written Emotional Disclosure on Eating Disorder Pathology in a Clinical Eating Disordered Population". A technique that has been found to be effective at relieving the physical and psychological symptoms associated with inhibiting emotions and emotional thoughts is written emotional disclosure. The goal of this study is to evaluate the effectiveness of written emotional disclosure on the remediation ...
What is the current status of trial NCT00766558?
This trial is currently completed. The enrollment target is 29 participants. The study started on 2009-06. Estimated completion is 2013-07.
Who is sponsoring clinical trial NCT00766558?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia